Is the occurrence of higher adverse effects associated with better oncological outcome in metastatic urothelial carcinoma patients treated with pembrolizumab?

被引：0
|
作者：
Hayakawa, Nozomi
Kikuchi, Eiji
Ogihara, Koichirou
Hattori, Seiya
Yoshimine, Shunsuke
Shirotake, Suguru
Okabe, Takashi
Yamashita, Ryo
Oya, Mototsugu
机构：
[1] Keio Univ, Dept Urol, Sch Med, Tokyo, Japan
[2] Kawasaki Municipal Hosp, Kawasaki, Kanagawa, Japan
[3] Saitama City Hosp, Saitama, Japan
[4] Saitama Med Univ, Int Med Ctr, Saitama, Japan
[5] Shizuoka Canc Ctr, Shizuoka, Japan
[6] Keio Univ, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.405
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
405
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab
    Tomisaki, Ikko
    Harada, Mirii
    Sakano, Shigeru
    Terado, Michikazu
    Hamasuna, Ryoichi
    Harada, Shuji
    Matsumoto, Hiroomi
    Akasaka, Soichiro
    Nagata, Yujiro
    Minato, Akinori
    Harada, Ken-Ichi
    Fujimoto, Naohiro
    ANTICANCER RESEARCH, 2023, 43 (01) : 269 - 274
  • [32] FECAL MICROBIOTA PROFILING OF PATIENTS TREATED WITH NEOADJUVANT PEMBROLIZUMAB FOR MUSCLE INVASIVE UROTHELIAL CARCINOMA
    Pederzoli, Filippo
    Locatelli, Irene
    Riba, Michela
    Bandini, Marco
    Raggi, Daniele
    Marandino, Laura
    Alchera, Elisa
    Giannatempo, Patrizia
    Provero, Paolo
    Lazarevic, Dejan
    Luciano, Roberta
    Gallina, Andrea
    Briganti, Alberto
    Montorsi, Francesco
    Salonia, Andrea
    Necchi, Andrea
    Alfano, Massimo
    JOURNAL OF UROLOGY, 2021, 206 : E726 - E726
  • [33] Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma
    Kang, Ho Won
    Seo, Sung Pil
    Kim, Won Tae
    Yun, Seok Joong
    Lee, Sang-Cheol
    Kim, Wun-Jae
    Hwang, Eu Chang
    Kang, Seok Ho
    Hong, Sung-Hoo
    Chung, Jinsoo
    Kwon, Tae Gyun
    Kim, Hyeon Hoe
    Kwak, Cheol
    Byun, Seok-Soo
    Kim, Yong-June
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (08) : 1551 - 1561
  • [34] Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma
    Ho Won Kang
    Sung Pil Seo
    Won Tae Kim
    Seok Joong Yun
    Sang-Cheol Lee
    Wun-Jae Kim
    Eu Chang Hwang
    Seok Ho Kang
    Sung-Hoo Hong
    Jinsoo Chung
    Tae Gyun Kwon
    Hyeon Hoe Kim
    Cheol Kwak
    Seok-Soo Byun
    Yong-June Kim
    International Journal of Clinical Oncology, 2020, 25 : 1551 - 1561
  • [35] Impact of lymph node dissection during surgery on the efficacy of pembrolizumab in patients with metastatic urothelial carcinoma
    Kanno, Toru
    Ito, Katsuhiro
    Kita, Yuki
    Mochizuki, Takanori
    Sano, Tomoyasu
    Yokomizo, Akira
    Abe, Takashige
    Tsuchihashi, Kazunari
    Tatarano, Shuichi
    Inokuchi, Junichi
    Takahashi, Atsushi
    Matsui, Yoshiyuki
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Saito, Ryoichi
    Kobayashi, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2025,
  • [36] Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy
    Dionese, Michele
    Bimbatti, Davide
    Pierantoni, Francesco
    Lai, Eleonora
    Erbetta, Elisa
    Cavasin, Nicolo
    Jubran, Salim
    Basso, Umberto
    Maruzzo, Marco
    ANTICANCER RESEARCH, 2024, 44 (10) : 4379 - 4386
  • [37] ASSOCIATION OF USE OF POTASSIUM COMPETITIVE ACID BLOCKERS AND EFFECTIVENESS OF PEMBROLIZUMAB IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA
    Fukuokaya, Wataru
    Kimura, Takahiro
    Komura, Kazumasa
    Uchimoto, Taizo
    Nishimura, Kazuki
    Oyama, Yu
    Abe, Hirokazu
    Azuma, Haruhito
    Miki, Jun
    Egawa, Shin
    JOURNAL OF UROLOGY, 2022, 207 (05): : E24 - E25
  • [38] ANTIBIOTIC USE AND SURVIVAL OF PATIENTS RECEIVING PEMBROLIZUMAB FOR CHEMOTHERAPY-RESISTANT METASTATIC UROTHELIAL CARCINOMA
    Ishiyama, Yudai
    Kondo, Tsunenori
    Nemoto, Yuki
    Kobari, Yuki
    Ishihara, Hiroki
    Tachibana, Hidekazu
    Yoshida, Kazuhiko
    Hashimoto, Yasunobu
    Takagi, Toshio
    Iizuka, Junpei
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2021, 206 : E248 - E248
  • [39] Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma
    Ishiyama, Yudai
    Kondo, Tsunenori
    Nemoto, Yuki
    Kobari, Yuki
    Ishihara, Hiroki
    Tachibana, Hidekazu
    Yoshida, Kazuhiko
    Hashimoto, Yasunobu
    Takagi, Toshio
    Iizuka, Junpei
    Tanabe, Kazunari
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 834.e21 - 834.e28
  • [40] Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study
    Tanabe, Kenji
    Kobayashi, Shuichiro
    Maezawa, Yuya
    Ishihara, Kensaku
    Inoue, Naoki
    Izumi, Keita
    Fujiwara, Motohiro
    Toide, Masahiro
    Yamamoto, Takanobu
    Uehara, Sho
    Araki, Saori
    Inoue, Masaharu
    Takazawa, Ryoji
    Numao, Noboru
    Ohtsuka, Yukihiro
    Tanaka, Hajime
    Yoshida, Soichiro
    Fujii, Yasuhisa
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (09) : 1302 - 1310
12345